LaFleur & Godfrey’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11M | Sell |
85,476
-2,676
| -3% | -$313K | 1.3% | 28 |
|
|
2026
Q1 | $10.6M | Sell |
88,152
-4,049
| -4% | -$467K | 1.32% | 28 |
|
|
2025
Q4 | $9.71M | Sell |
92,201
-1,117
| -1% | -$105K | 1.18% | 32 |
|
|
2025
Q3 | $7.83M | Sell |
93,318
-3,656
| -4% | -$301K | 0.95% | 35 |
|
|
2025
Q2 | $7.68M | Sell |
96,974
-5,008
| -5% | -$398K | 0.96% | 35 |
|
|
2025
Q1 | $9.15M | Sell |
101,982
-691
| -0.7% | -$64.5K | 1.24% | 28 |
|
|
2024
Q4 | $10.2M | Sell |
102,673
-410
| -0.4% | -$42.3K | 1.4% | 23 |
|
|
2024
Q3 | $11.7M | Sell |
103,083
-2,330
| -2% | -$277K | 1.61% | 18 |
|
|
2024
Q2 | $13.1M | Sell |
105,413
-1,186
| -1% | -$153K | 1.91% | 16 |
|
|
2024
Q1 | $14.1M | Sell |
106,599
-6,668
| -6% | -$822K | 2.08% | 15 |
|
|
2023
Q4 | $12.3M | Sell |
113,267
-562
| -0.5% | -$58.3K | 1.84% | 16 |
|
|
2023
Q3 | $11.7M | Sell |
113,829
-625
| -0.5% | -$67.4K | 1.88% | 16 |
|
|
2023
Q2 | $13.2M | Sell |
114,454
-660
| -0.6% | -$74.9K | 1.98% | 15 |
|
|
2023
Q1 | $12.2M | Sell |
115,114
-5,906
| -5% | -$638K | 2.01% | 14 |
|
|
2022
Q4 | $13.4M | Sell |
121,020
-20,150
| -14% | -$2.06M | 2.24% | 14 |
|
|
2022
Q3 | $12.2M | Sell |
141,170
-11,323
| -7% | -$1.01M | 2.17% | 13 |
|
|
2022
Q2 | $13.9M | Sell |
152,493
-6,620
| -4% | -$587K | 2.2% | 13 |
|
|
2022
Q1 | $13.1M | Buy |
159,113
+2,238
| +1% | +$176K | 1.75% | 17 |
|
|
2021
Q4 | $12M | Buy |
156,875
+5,148
| +3% | +$410K | 1.54% | 19 |
|
|
2021
Q3 | $11.4M | Sell |
151,727
-1,597
| -1% | -$121K | 1.57% | 18 |
|
|
2021
Q2 | $11.9M | Buy |
153,324
+25,327
| +20% | +$1.88M | 1.71% | 17 |
|
|
2021
Q1 | $9.41M | Sell |
127,997
-32,059
| -20% | -$2.36M | 1.83% | 22 |
|
|
2020
Q4 | $12.5M | Sell |
160,056
-2,247
| -1% | -$172K | 2.56% | 11 |
|
|
2020
Q3 | $12.8M | Sell |
162,303
-5,783
| -3% | -$453K | 2.9% | 11 |
|
|
2020
Q2 | $12.4M | Sell |
168,086
-1,098
| -0.6% | -$82.7K | 3.17% | 10 |
|
|
2020
Q1 | $12.4M | Sell |
169,184
-4,411
| -3% | -$347K | 3.7% | 6 |
|
|
2019
Q4 | $15.1M | Sell |
173,595
-2,070
| -1% | -$170K | 3.4% | 8 |
|
|
2019
Q3 | $14.1M | Sell |
175,665
-2,670
| -1% | -$214K | 3.46% | 8 |
|
|
2019
Q2 | $14.3M | Sell |
178,335
-324
| -0.2% | -$24.8K | 3.56% | 8 |
|
|
2019
Q1 | $14.2M | Sell |
178,659
-7,744
| -4% | -$579K | 3.66% | 10 |
|
|
2018
Q4 | $13.6M | Sell |
186,403
-34,530
| -16% | -$2.44M | 3.83% | 6 |
|
|
2018
Q3 | $15M | Sell |
220,933
-3,210
| -1% | -$205K | 3.6% | 8 |
|
|
2018
Q2 | $13M | Sell |
224,143
-4,620
| -2% | -$261K | 3.24% | 9 |
|
|
2018
Q1 | $11.9M | Sell |
228,763
-12,654
| -5% | -$683K | 2.98% | 11 |
|
|
2017
Q4 | $13M | Sell |
241,417
-12,094
| -5% | -$670K | 3.18% | 9 |
|
|
2017
Q3 | $15.5M | Sell |
253,511
-1,577
| -0.6% | -$95.6K | 4.06% | 5 |
|
|
2017
Q2 | $15.6M | Buy |
255,088
+3,563
| +1% | +$217K | 4.1% | 4 |
|
|
2017
Q1 | $15.3M | Sell |
251,525
-1,106
| -0.4% | -$67.1K | 4.12% | 4 |
|
|
2016
Q4 | $14.2M | Buy |
252,631
+12,199
| +5% | +$714K | 3.98% | 5 |
|
|
2016
Q3 | $14.3M | Buy |
240,432
+11,989
| +5% | +$701K | 4.13% | 6 |
|
|
2016
Q2 | $12.6M | Buy |
228,443
+24,209
| +12% | +$1.29M | 3.72% | 6 |
|
|
2016
Q1 | $10.3M | Buy |
204,234
+68,004
| +50% | +$3.33M | 3.13% | 8 |
|
|
2015
Q4 | $6.87M | Buy |
136,230
+18,194
| +15% | +$917K | 2.03% | 13 |
|
|
2015
Q3 | $5.56M | Buy |
+118,036
| New | +$6.27M | 1.66% | 19 |
|
Other funds holding MRK
ECSS
ATO
LaFleur & Godfrey's MRK Position: Q2 2026 in Review
LaFleur & Godfrey reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $313K and leaving 85,476 shares worth $11M. The position accounts for 1.3% of the portfolio, ranked #28.
LaFleur & Godfrey first reported a position in MRK in Q3 2015 and has held it in 44 quarters since. The position peaked at $15.6M in Q2 2017. 1,561 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- LaFleur & Godfrey held 85,476 shares of Merck worth $11M as of Q2 2026.
- LaFleur & Godfrey sold 2,676 Merck shares in Q2 2026, an estimated $313K.
- Merck made up 1.3% of LaFleur & Godfrey's portfolio in Q2 2026, its #28 holding.
- LaFleur & Godfrey first reported a position in Merck in Q3 2015 and has held it in 44 quarters since.
- LaFleur & Godfrey's Merck position peaked at $15.6M in Q2 2017.
- 1,561 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.